Mcs5a influences tumor progression via the immune system (T cells) in a FBXO10-dependent manner – analogous to a mechanism in human T lymphocytes (Xu et al., 2014) that is associated with human breast cancer risk (Samuelson et al., 2007). Here, FBXO10 is linked to neoplasm.